Featured Research

from universities, journals, and other organizations

Long-term use of some high blood pressure drugs associated with increased risk of breast cancer in postmenopausal women

Date:
August 5, 2013
Source:
Fred Hutchinson Cancer Research Center
Summary:
Older women who take certain types of medication to combat high blood pressure may be putting themselves at greater risk for developing breast cancer, according to a new study.

Older women who take certain types of medication to combat high blood pressure may be putting themselves at greater risk for developing breast cancer, according to a new study by a team of Fred Hutchinson Cancer Research Center scientists led by Christopher Li, M.D., Ph.D. The study is the first to observe that long-term use of a class of antihypertensive drugs known as calcium-channel blockers in particular are associated with breast cancer risk.

The team's findings will be published online Aug. 5 in JAMA Internal Medicine.

Antihypertensive drugs are the most frequently prescribed type of medications in the United States, with more than 678 million prescriptions filled in 2010, nearly 98 million of which were for calcium-channel blockers.

Despite widespread and often long-term use of these drugs, studies and evidence linking antihypertensives to breast cancer have been sparse and inconsistent.

"Because hypertension is a chronic condition, most people with high blood pressure use antihypertensive drugs chronically and will often stay on the same regimen for long periods of time," Li said. "Characterizing their potential associations with the most common cancer in women is an important clinical and public health issue, particularly with the increasing availability of alternative options to manage hypertension," said Li, head of the Translational Research Program and member of the Public Health Sciences Division at Fred Hutch.

In addition to calcium-channel blockers, other classes of antihypertensive drugs include angiotensin-converting-enzyme (ACE) inhibitors, angiotensin-receptor blockers, beta blockers and diuretics. Combinations of such drugs are also prescribed. "Each drug has different potential benefits as well as side effects," Li said. "Choice of which regimen a patient is given depends on their tolerance of medication, other conditions, and whether their hypertension can be managed by a single drug or requires a combination of drugs."

The purpose of the Hutch study was to assess the relationship between the major classes of antihypertensive drugs and risk of the two most common histological types of breast cancers in the United States: invasive ductal carcinomas, which represent approximately 70 percent of all breast cancers; and invasive lobular carcinomas, which represent an estimated 20 percent.

The study's key finding was that women currently taking calcium-channel blockers who have used them for 10 years or longer had an approximately two and a half times higher risk of both invasive ductal and invasive lobular cancers compared to those who never used such calcium-channel blockers and compared to users of other forms of antihypertensives. In contrast, the study found that use of other classes of antihypertensive drugs, including diuretics, beta blockers and angiotensin-receptor blockers, were not associated with an increased risk of breast cancer, even when used long term.

Li's team interviewed 1,763 study participants, all between the ages of 55-74 from the Puget Sound region, including 880 with invasive ductal cancer, 1,027 with invasive lobular cancer, and 856 cancer-free controls. Participants were interviewed in person to establish detailed histories of hypertension and heart disease, as well as risk factors for cancer, including family history, obesity, smoking and alcohol use. Through a series of structured questions, researchers also gathered detailed data regarding use of antihypertensive drugs, including beginning and end dates of use, drug names, dose, route of administration, pattern of use and indication.

While calcium-channel blockers in particular appear to have an implication for increased cancer risk in cases of long-term use, the drugs have a broad spectrum of physiological effects, and more research will be required to understand the underlying biological mechanisms potentially responsible for the added risk. Calcium-channel blockers function by regulating the influx of calcium into muscle cells, decreasing arterial resistance and heart muscle oxygen demand. Some hypothesize that these drugs may increase cancer risk because they inhibit programmed cell death, or apoptosis, but supporting evidence is lacking.

The National Cancer Institute funded the study.


Story Source:

The above story is based on materials provided by Fred Hutchinson Cancer Research Center. Note: Materials may be edited for content and length.


Journal References:

  1. Patricia F. Coogan, ScD1. Calcium-Channel Blockers and Breast Cancer A Hypothesis Revived. JAMA Intern Med., 2013 DOI: 10.1001/jamainternmed.2013.9069
  2. Christopher I. Li et al. Use of Antihypertensive Medications and Breast Cancer Risk Among Women Aged 55 to 74 Years. JAMA Intern Med., 2013 DOI: 10.1001/jamainternmed.2013.9071

Cite This Page:

Fred Hutchinson Cancer Research Center. "Long-term use of some high blood pressure drugs associated with increased risk of breast cancer in postmenopausal women." ScienceDaily. ScienceDaily, 5 August 2013. <www.sciencedaily.com/releases/2013/08/130805222651.htm>.
Fred Hutchinson Cancer Research Center. (2013, August 5). Long-term use of some high blood pressure drugs associated with increased risk of breast cancer in postmenopausal women. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2013/08/130805222651.htm
Fred Hutchinson Cancer Research Center. "Long-term use of some high blood pressure drugs associated with increased risk of breast cancer in postmenopausal women." ScienceDaily. www.sciencedaily.com/releases/2013/08/130805222651.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins